Business · 30/07/2019Updated: 10/17/2026 · 1 min read
FDA Announces Availability of Draft Guidance for Rare Pediatric Disease Priority Review Vouchers
Summary
The FDA is releasing a revised draft guidance for industry on the Rare Pediatric Disease Priority Review Vouchers program, which aims to encourage development of new treatments for rare pediatric diseases.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →